• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

L-精氨酸对肝硬化腹水患者的全身低血压及利尿作用:一氧化氮的作用

Systemic hypotension and diuresis by L-arginine in cirrhotic patients with ascites: role of nitric oxide.

作者信息

Tajiri K, Miyakawa H, Izumi N, Marumo F, Sato C

机构信息

Second Department of Internal Medicine, Faculty of Medicine, Tokyo Medical and Dental University, Japan.

出版信息

Hepatology. 1995 Nov;22(5):1430-5.

PMID:7590659
Abstract

To investigate the role of nitric oxide in renal function and hemodynamics in cirrhotic patients with ascites, L-arginine (30 g in 300 mL of distilled water), a substrate for nitric oxide synthase, was infused into six cirrhotic patients with ascites, and the effects were compared with those of saline infusion. Healthy controls (n = 5) were also studied under the same conditions. In the patients, L-arginine infusion significantly decreased systolic and diastolic blood pressures while markedly increasing urinary flow and urinary sodium excretion; no significant changes were seen with saline infusion. In controls, only diastolic blood pressure was decreased by L-arginine infusion, whereas urinary flow and urinary sodium excretion were increased by both L-arginine and saline infusion. In both groups, a similar increase of plasma atrial natriuretic factor (ANF) was seen with L-arginine and saline infusions; endothelin and catecholamines were not affected by either infusion. In both groups, plasma levels of vasopressin were increased by L-arginine infusion. In the cirrhotic patients, urinary excretions of cyclic guanosine monophosphate (cGMP) and nitrates/nitrites (NOx) were significantly increased by L-arginine infusion, whereas no significant changes were seen with saline infusion. In controls, only the excretion of cGMP was increased by L-arginine infusion. In summary, L-arginine infusion induces diuresis and natriuresis accompanied by increased excretions of cGMP and NOx in cirrhotic patients with ascites. This differs from the response in controls, where the increase in urinary sodium excretion is not accompanied by an increase in markers of increased nitric oxide synthesis.

摘要

为研究一氧化氮在肝硬化腹水患者肾功能和血流动力学中的作用,将一氧化氮合酶的底物L-精氨酸(30克溶于300毫升蒸馏水中)输注给6例肝硬化腹水患者,并将其效果与输注生理盐水的效果进行比较。还在相同条件下对健康对照者(n = 5)进行了研究。在患者中,输注L-精氨酸可显著降低收缩压和舒张压,同时显著增加尿流量和尿钠排泄;输注生理盐水则未见明显变化。在对照者中,输注L-精氨酸仅使舒张压降低,而L-精氨酸和生理盐水输注均使尿流量和尿钠排泄增加。在两组中,输注L-精氨酸和生理盐水后血浆心房利钠因子(ANF)均有类似升高;内皮素和儿茶酚胺均不受任何一种输注的影响。在两组中,输注L-精氨酸均使血管加压素的血浆水平升高。在肝硬化患者中,输注L-精氨酸可使环磷酸鸟苷(cGMP)和硝酸盐/亚硝酸盐(NOx)的尿排泄显著增加,而输注生理盐水则未见明显变化。在对照者中,输注L-精氨酸仅使cGMP的排泄增加。总之,输注L-精氨酸可在肝硬化腹水患者中诱导利尿和利钠,并伴有cGMP和NOx排泄增加。这与对照者的反应不同,对照者尿钠排泄增加并不伴有一氧化氮合成增加标志物的增加。

相似文献

1
Systemic hypotension and diuresis by L-arginine in cirrhotic patients with ascites: role of nitric oxide.L-精氨酸对肝硬化腹水患者的全身低血压及利尿作用:一氧化氮的作用
Hepatology. 1995 Nov;22(5):1430-5.
2
[Renal effects of the chronic inhibition of nitric oxide synthesis in cirrhotic rats with ascites].[一氧化氮合成慢性抑制对肝硬化腹水大鼠肾脏的影响]
Nefrologia. 2001;21(6):556-64.
3
L-arginine infusion induces hypotension and diuresis/natriuresis with concomitant increased urinary excretion of nitrite/nitrate and cyclic GMP in humans.在人类中,输注L-精氨酸会引发低血压以及利尿/利钠作用,同时伴有尿中亚硝酸盐/硝酸盐及环磷酸鸟苷排泄增加。
Clin Exp Pharmacol Physiol. 1992 Sep;19(9):619-25. doi: 10.1111/j.1440-1681.1992.tb00514.x.
4
Enhanced external counterpulsation: a new technique to augment renal function in liver cirrhosis.增强型体外反搏:一种改善肝硬化患者肾功能的新技术。
Nephrol Dial Transplant. 2005 May;20(5):920-6. doi: 10.1093/ndt/gfh755. Epub 2005 Mar 23.
5
Refractory ascites in cirrhosis: roles of volume expansion and plasma atrial natriuretic factor level elevation.肝硬化难治性腹水:容量扩张和血浆心钠素水平升高的作用
Hepatology. 1993 Sep;18(3):519-28.
6
Nitric oxide synthase inhibition does not improve renal function in cirrhotic patients with ascites.一氧化氮合酶抑制并不能改善肝硬化腹水患者的肾功能。
Am J Gastroenterol. 2003 Jan;98(1):180-6. doi: 10.1111/j.1572-0241.2003.07174.x.
7
[Pathophysiologic and clinical relevance of atrial natriuretic factor in patients with cirrhosis of the liver].
Z Kardiol. 1988;77 Suppl 2:99-103.
8
Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.低剂量心房利钠肽在代偿期肝硬化中的心血管和肾脏效应
Am J Gastroenterol. 1997 May;92(5):852-7.
9
[Pressor, renal and endocrine effects of systemic infusion of L-arginine in hypertensive patients].
Ann Ital Med Int. 1995 Apr-Jun;10(2):107-12.
10
Renal functional reserve and nitric oxide in patients with compensated liver cirrhosis.
Hepatology. 1997 Oct;26(4):858-64. doi: 10.1002/hep.510260409.

引用本文的文献

1
Recent advances in the management of pruritus in chronic liver diseases.慢性肝脏疾病瘙痒管理的最新进展。
World J Gastroenterol. 2017 May 21;23(19):3418-3426. doi: 10.3748/wjg.v23.i19.3418.
2
The role of nitric oxide in systemic and hepatic haemodynamics in the rat in vivo.一氧化氮在大鼠体内全身及肝脏血流动力学中的作用。
Naunyn Schmiedebergs Arch Pharmacol. 2003 Aug;368(2):142-9. doi: 10.1007/s00210-003-0774-8. Epub 2003 Jul 29.
3
Sodium handling in patients with well compensated cirrhosis is dependent on the severity of liver disease and portal pressure.
肝硬化代偿良好患者的钠代谢取决于肝脏疾病的严重程度和门静脉压力。
Gut. 2000 Apr;46(4):527-33. doi: 10.1136/gut.46.4.527.
4
Enhanced urinary excretion of cGMP in liver cirrhosis. Relationship to hemodynamic changes, neurohormonal activation, and urinary sodium excretion.肝硬化患者尿中环鸟苷酸排泄增加。与血流动力学变化、神经激素激活及尿钠排泄的关系。
Dig Dis Sci. 1997 Jul;42(7):1416-20. doi: 10.1023/a:1018846122586.